PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration

被引:0
作者
Wenji Piao
Lushen Li
Vikas Saxena
Jegan Iyyathurai
Ram Lakhan
Yigang Zhang
Isadora Tadeval Lape
Christina Paluskievicz
Keli L. Hippen
Young Lee
Emma Silverman
Marina W. Shirkey
Leonardo V. Riella
Bruce R. Blazar
Jonathan S. Bromberg
机构
[1] Center for Vascular and Inflammatory Diseases,Department of Surgery
[2] University of Maryland School of Medicine,Department of Microbiology and Immunology
[3] University of Maryland School of Medicine,undefined
[4] Division of Blood & Marrow Transplant & Cellular Therapy,undefined
[5] Department of Pediatrics,undefined
[6] University of Minnesota Cancer Center,undefined
[7] Center for Transplantation Sciences,undefined
[8] Department of Surgery,undefined
[9] Massachusetts General Hospital,undefined
[10] Boston,undefined
[11] Massachusetts,undefined
[12] University of Maryland School of Medicine,undefined
来源
Nature Communications | / 13卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Programmed death-1 (PD-1) and its ligand PD-L1 are checkpoint molecules which regulate immune responses. Little is known about their functions in T cell migration and there are contradictory data about their roles in regulatory T cell (Treg) function. Here we show activated Tregs and CD4 effector T cells (Teffs) use PD-1/PD-L1 and CD80/PD-L1, respectively, to regulate transendothelial migration across lymphatic endothelial cells (LECs). Antibody blockade of Treg PD-1, Teff CD80 (the alternative ligand for PD-L1), or LEC PD-L1 impairs Treg or Teff migration in vitro and in vivo. PD-1/PD-L1 signals through PI3K/Akt and ERK to regulate zipper junctional VE-cadherin, and through NFκB-p65 to up-regulate VCAM-1 expression on LECs. CD80/PD-L1 signaling up-regulates VCAM-1 through ERK and NFκB-p65. PD-1 and CD80 blockade reduces tumor egress of PD-1high fragile Tregs and Teffs into draining lymph nodes, respectively, and promotes tumor regression. These data provide roles for PD-L1 in cell migration and immune regulation.
引用
收藏
相关论文
共 89 条
  • [1] Keir ME(2008)PD-1 and its ligands in tolerance and immunity Annu. Rev. Immunol. 26 677-704
  • [2] Butte MJ(2004)PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells Proc. Natl Acad. Sci. USA 101 10691-10696
  • [3] Freeman GJ(2000)Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation J. Exp. Med. 192 1027-1034
  • [4] Sharpe AH(1996)Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes Int. Immunol. 8 765-772
  • [5] Latchman YE(2002)Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells Microcirculation 9 133-145
  • [6] Freeman GJ(2016)Tumor-intrinsic PD-L1 signals regulate cell growth, pathogenesis, and autophagy in ovarian cancer and melanoma Cancer Res. 76 6964-6974
  • [7] Agata Y(2002)Expression of programmed death 1 ligands by murine T cells and APC J. Immunol. 169 5538-5545
  • [8] Eppihimer MJ(2005)Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4 Nat. Immunol. 6 280-286
  • [9] Clark CA(2006)Restoring function in exhausted CD8 T cells during chronic viral infection Nature 439 682-687
  • [10] Yamazaki T(2006)Tissue expression of PD-L1 mediates peripheral T cell tolerance J. Exp. Med. 203 883-895